DABIGATRAN ETEXILATE 75 MG CAP

Dabigatran Etexilate
$0.8478per EA
Low Outlier

Strength

75 mg/1

NDC

00378026591

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208067

On Market Since

2/25/2025

Pharmacological Classes

Direct Thrombin Inhibitor
Thrombin Inhibitors

Price History

1W

0.0%

1M

-10.0%

3M

-19.6%

6M

-24.7%

1Y

-50.0%

3Y

N/A

5Y

N/A

All

-52.1%